2023 annual financial data
Ascendis Pharma 2023 Operating margin
Ascendis Pharma 2023 operating margin with verified reported values.
Direct answer
Operating margin was -170.79%.
Operating income was -455,541,000 EUR and net income was -481,447,000 EUR.
Operating cash flow was -467,361,000 EUR.
Get free Ascendis Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 266,718,000 EUR
- Operating income
- -455,541,000 EUR
- Net income
- -481,447,000 EUR
- Operating cash flow
- -467,361,000 EUR